跳至主要内容
临床试验/NL-OMON24380
NL-OMON24380尚未招募不适用

The impact of a SmartPhone applicatiOn for skin cancer risk assessmenT on the healthcare system (SPOT-study): A randomized controlled trial.

Department of Dermatology, Erasmus MC Cancer Institute Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands0 个研究点目标入组 200,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200,000

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • To be eligible to participate in this study, a subject must meet all of the following inclusion criteria:
  • -Ability to give informed consent for this study.
  • -= 18 years old.
  • -Receive health care insurance from DSW.

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • -Persons without an email address.
  • -Persons without a (compatible) smartphone.
  • -Persons without an internet connection.

研究者

发起方
Department of Dermatology, Erasmus MC Cancer Institute Dr. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands

相似试验